Novartis sells joint venture stake to GSK for $13 billion
Swiss pharmaceutical firm Novartis says it is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.
Tuesday, March 27, 2018
Novartis sells joint venture stake to GSK for $13 billion
Novartis sells joint venture stake to GSK for $13 billion
Swiss pharmaceutical firm Novartis says it is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.
Related Posts:
0 comments:
Post a Comment